Summary

Facial Injectables are the face skin fillers which are used in many applications like dark circles removal, uplifting of eyebrows, thinning of the lips, enhancement of cheekbones and others applications. Facial injectables are also used to reduce wrinkles and smoothen skin appearance caused by aging, acne or scars. The major application areas are face including Nasolabial fold, cheeks, lips, corners of the eye and for enhancing appearance of dorsal area of hands. In 2023, the global facial injectables market was valued at US$8.86 billion, and is probable to reach US$18.89 billion by 2029.

Facial injectables is one of the fastest growing segments of the medical aesthetics market. The growing number of plastic surgeons and their networks is driving the need for facial injectables. Other practitioners, including as surgeons, were also granted Food and Drug Administration (FDA) approval to use face injectables in their clinics. Furthermore, the facial injectable market is predicted to grow as the senior population grows and new facial injectables, such as synthetic calcium hydroxylaptite (CaHA) fillers, become available. As a result, the facial injectable market expanded over the forecast period. Increased demand for face injectables, returning customers, new indication, geographic expansion, positive government assistance in terms of product approval for new application areas, and commercialization of creative solutions in the facial injectable industry drive mergers, collaborations, partnerships, and agreements among facial injectable firms. The global facial injectables market value is projected to grow at a CAGR of 12.60%, during the forecast period of 2024-2029.


Market Segmentation Analysis:

By Type: According to the report, the global facial injectables market is segmented into two types : Derma Fillers and Neuromodulator Aesthetics. Derma Fillers segment acquired majority of share in the market in 2023, because of the growing trend of ageless beauty, increasing desire to maintain a youthful look. Whereas, the same segment has the fastest CAGR as dual-income households and rising disposable income in both developing and developed countries would fuel market expansion for dermal fillers in the coming years.

By Application: According to the report, the global facial injectables market is segmented into four applications: Facial Line Correction, Face Lift, Lip Treatment and Others. Facial Line Correction segment acquired majority of share in the market in 2023 as the senior population developed facial lines and the demand for facial line correction treatment method increased. Whereas, the Face Lift segment has the fastest CAGR because of the global population's desire for a more defined and appealing facial appearance.

By Ends User: According to the report, the global facial injectables market is bifurcated into three end users: Hospitals and Medspa, Dermatology and Cosmetic Centers and Others. Hospitals and Medspa segment acquired majority of share in the market in 2023, as these institutions adhere to all regulatory laws and standards established by the government and must be owned by a physician. Whereas, Dermatology and Cosmetic Centers segment is expected to have the highest CAGR in the future as affordability has spurred demand for facial injectables, resulting in an increase in the number of patients attending Dermatology and Cosmetic Centers.

By Region: The report provides insight into the facial injectables market based on the geographical operations, namely North America, Europe, Asia Pacific, and Rest of the World. North America facial injectables market enjoyed the highest market share in 2023, due to higher knowledge regarding aesthetic surgical operations, technical improvements in cosmetic procedures, the existence of important market competitors, the growing elderly population, and the increased desire for non-invasive aesthetic procedures. During the forecast period, new product releases by prominent industry players in North America would also drive market growth. The market for North America facial injectables is dominated by the US, as there are key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing demand for non-surgical aesthetic procedures in the US.

Subsequently, the US facial injectables market can be divided into two types namely, Derma fillers and Neuromodulator aesthetics. The derma filler segment is sub segmented into six products, such as, hyaluronic acid, calcium hydroxylapatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), and others. The facial injectables market in the Asia Pacific region would experience fastest growth in the coming years, driven by several key factors. The strong increase in disposable income in Asian countries, growing awareness of aesthetic procedures, and increasing focus of prominent market players in terms of new product launches contribute to the region's growth. Within Asia Pacific, China dominates the market. The Chinese face injectables business has grown in recent years as consumers demand sharper features and as private aesthetics chains have expanded.


Global Facial Injectables Market Dynamics:

Growth Drivers: As people strive to retain a youthful and revitalized appearance without having invasive surgery, these therapies have grown in popularity. The rise in disposable money is a major factor driving the growth of the facial injectables market. As many countries' economies and living conditions have improved, customers have more money available for discretionary spending, including cosmetic operations. Further, the market is expected to increase due to increasing geriatric population, increasing beauty consciousness among people, growing healthcare expenditure, shift in consumer preference for minimally invasive procedures, etc.

Challenges: The market's expansion is projected to be hampered by adverse effects associated with certain facial injectables. Adverse effects of some other facial injectables, such as hyaluronic acid, include legal & regulatory issues, and safety concerns, which are anticipated to impede the market growth. There are certain adverse effects that are associated with application of hyaluronic acid cycles, such as itching and inflammation. The repetitive pain associated with multiple injection cycles is also a deterrent. The other challenges that facial injectables market faces include stringent regulators and costly treatments, etc.

Trends: One of the most distinct and pervasive trends observed in the global facial injectables market is that a growing proportion of the male population is predicted to use facial injectables. During the forecast period, the male population is likely to use a variety of fillers, including Botulinum toxin and dermal fillers. For example, a rising number of younger men are opting for tissue fillers before their skin begins to age. More trends in the market are believed to augment the growth of facial injectables market during the forecasted period include, new product launches and emerging markets, innovation, younger demographics seeking preventive treatments, AI and digital tools etc.


Impact Analysis of COVID-19 and Way Forward:

The COVID-19 epidemic had a negative impact on market trends in facial injectables market. As these procedures are considered non-essential, these were among the first healthcare market procedures to witness widespread restriction and cancellations. In conclusion, the COVID-19 pandemic initially caused a significant decline in the facial injectables market due to the closure of clinics, reduced consumer confidence, and supply chain disruptions. However, as the situation improved and safety measures were implemented, the market showed signs of recovery.


Competitive Landscape and Recent Developments:

Global facial injectables market is moderately fragmented, with AbbVie dominating the market due to the companyfs strong facial injectables portfolio comprising dermal fillers and Botulinum toxin for cosmetic procedures. AbbVie is the market leader in the US with approx. 80% revenue share and high-60s volume share in neuromodulators. Key players of global facial injectables market are:
AbbVie Inc. (Allergan Inc.)
Ipsen
Revance Therapeutics, Inc.
Croma-Pharma GmbH
Merz Pharma GmbH & Co. KGaA
Suneva Medical Inc.
Medytox Inc.
Sinclair Pharma Plc
Prollenium Medical Technologies Inc.
Galderma S.A.
Evolus, Inc.

The key players are constantly investing in strategic initiatives, such as new product launches, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance in May 2023, Evolus, a company, announced entry into the US dermal filler market with the introduction of Evolysse. This first-generation cold technology hyaluronic acid (HA) product, developed by Symatese, marks a significant expansion for Evolus. Additionally, Evolus has a portfolio of five fillers currently in late-stage development, with the anticipation of the first approval in the first half of 2025. In January 2023, Galderma unveiled a revolutionary solution called FACE by Galderma, aimed at assisting healthcare professionals in expanding their practice and enhancing patient satisfaction. This cutting-edge augmented reality application employs digital facial assessment to simulate the outcomes of injectable treatments in real time.

 

ページTOPに戻る

Table of Contents

1. Executive Summary

2. Introduction

2.1 Facial Injectables: An Overview
2.1.1 Advantages of Derma Fillers

2.2 Facial Injectables Segmentation: An Overview
2.2.1 Facial Injectables Segmentation

3. Global Market Analysis

3.1 Global Facial Injectables Market: An Analysis

3.1.1 Global Facial Injectables Market: An Overview
3.1.2 Global Facial Injectables Market by Value
3.1.3 Global Facial Injectables Market by Type (Derma Fillers and Neuromodulator Aesthetics)
3.1.4 Global Facial Injectables Market by Application (Facial Line Correction, Face Lift, Lip Treatment and Others)
3.1.5 Global Facial Injectables Market by End User (Hospitals and Medspa, Dermatology and Cosmetic Centers and Others)
3.1.6 Global Facial Injectables Market by Region (North America, Europe, Asia Pacific and Rest of the World)

3.2 Global Facial Injectables Market: Type Analysis

3.2.1 Global Facial Injectables Market by Type: An Overview
3.2.2 Global Derma Fillers Facial Injectables Market by Value
3.2.3 Global Derma Fillers Facial Injectables Market by Product (Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Fat Injection and Others)
3.2.4 Global Derma Fillers Facial Injectables Market Product by Value
3.2.5 Global Neuromodulator Aesthetics Facial Injectables Market by Value

3.3 Global Facial Injectables Market: Application Analysis

3.3.1 Global Facial Injectables Market by Application: An Overview
3.3.2 Global Facial Line Correction Treatment Injectables Market by Value
3.3.3 Global Face Lift Injectables Market by Value
3.3.4 Global Lip Treatment Injectables Market by Value
3.3.5 Global Other Facial Injectables Market by Value

3.4 Global Facial Injectables Market: End User Analysis

3.4.1 Global Facial Injectables Market by End User: An Overview
3.4.2 Global Hospitals and Medspa Facial Injectables Market by Value
3.4.3 Global Dermatology and Cosmetic Centers Facial Injectables Market by Value
3.4.4 Global Other End Users Facial Injectables Market by Value

4. Regional Market Analysis

4.1 North America Facial Injectables Market: An Analysis

4.1.1 North America Facial Injectables Market: An Overview
4.1.2 North America Facial Injectables Market by Value
4.1.3 North America Facial Injectables Market by Region (The US, Canada and Mexico)
4.1.4 The US Facial Injectables Market by Value
4.1.5 The US Facial Injectables Market by Type (Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), and Others)
4.1.6 The US Neuromodulator Aesthetics Facial Injectables Market by Value
4.1.7 The US Derma Fillers Facial Injectables Market by Value
4.1.8 The US Derma Fillers Facial Injectables Market Product by Value
4.1.9 Canada Facial Injectables Market by Value
4.1.10 Mexico Facial Injectables Market by Value

4.2 Europe Facial Injectables Market: An Analysis

4.2.1 Europe Facial Injectables Market: An Overview
4.2.2 Europe Facial Injectables Market by Value
4.2.3 Europe Facial Injectables Market by Type (Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Fat Injection and Others)
4.2.4 Europe Derma Fillers Facial Injectables Market by Value
4.2.5 Europe Derma Fillers Facial Injectables Market Product by Value
4.2.6 Europe Neuromodulator Aesthetics Facial Injectables Market by Value
4.2.7 Europe Facial Injectables Market by Region (Germany, France, UK, Italy, Spain and Rest of Europe)
4.2.8 Germany Facial Injectables Market by Value
4.2.9 France Facial Injectables Market by Value
4.2.10 UK Facial Injectables Market by Value
4.2.11 Italy Facial Injectables Market by Value
4.2.12 Spain Facial Injectables Market by Value
4.2.13 Rest of Europe Facial Injectables Market by Value

4.3 Asia Pacific Facial Injectables Market: An Analysis

4.3.1 Asia Pacific Facial Injectables Market: An Overview
4.3.2 Asia Pacific Facial Injectables Market by Value
4.3.3 Asia Pacific Facial Injectables Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.4 China Facial Injectables Market by Value
4.3.5 Japan Facial Injectables Market by Value
4.3.6 India Facial Injectables Market by Value
4.3.7 South Korea Facial Injectables Market by Value
4.3.8 Rest of Asia Pacific Facial Injectables Market by Value

4.4 Rest of the World Facial Injectables Market: An Analysis

4.4.1 Rest of the World Facial Injectables Market: An Overview
4.4.2 Rest of the World Facial Injectables Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Facial Injectables
5.1.2 Post COVID-19 Impact

6. Market Dynamics

6.1 Growth Drivers
6.1.1 Increasing Geriatric Population
6.1.2 Amplified Disposable Income
6.1.3 Rising Social Media Influence
6.1.4 Growing Healthcare Expenditure
6.1.5 Increasing Beauty Consciousness among People
6.1.6 Shift In Consumer Preference For Minimally Invasive Procedures

6.2 Challenges
6.2.1 Adverse Effects Associated With Certain Facial Injectables
6.2.2 Stringent Regulators
6.2.3 Costly Treatments

6.3 Market Trends
6.3.1 New Product Launches
6.3.2 Increased Male Aesthetics
6.3.3 Younger Demographics Seeking Preventive Treatments
6.3.4 Artificial Intelligence (AI) and Digital Tools
6.3.5 Emerging Markets
6.3.6 Innovations

7. Competitive Landscape

7.1 The US Facial Injectables Market Players: Competitive Landscape

7.1.1 The US Neuromodulators Market Players: Competitive Landscape
7.1.2 The US Neuromodulators Facial Injectables Players by Market Share
7.1.3 The US Derma Fillers Market Players: Competitive Landscape
7.2 Europe Facial Injectables Market Players: Competitive Landscape
7.2.1 Europe Neuromodulators Market Players: Competitive Landscape
7.2.2 Europe Derma Fillers Market Players: Competitive Landscape

8. Company Profiles

8.1 AbbVie Inc. (Allergan Inc.)
8.1.1 Business Overview
8.1.2 Operating Regions
8.1.3 Business Strategy

8.2 Ipsen
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 Revance Therapeutics, Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy

8.4 Croma-Pharma GmbH
8.4.1 Business Overview
8.4.2 Operating Regions
8.4.3 Business Strategy

8.5 Merz Pharma GmbH & Co. KGaA
8.5.1 Business Overview
8.5.2 Business Strategy

8.6 Suneva Medical Inc.
8.6.1 Business Overview
8.6.2 Business Strategy

8.7 Medytox Inc.
8.7.1 Business Overview
8.7.2 Business Strategy

8.8 Sinclair Pharma Plc
8.8.1 Business Overview
8.8.2 Business Strategy

8.9 Galderma S.A.
8.9.1 Business Overview
8.9.2 Business Strategy

8.10 Evolus, Inc.
8.10.1 Business Overview
8.10.2 Business Strategy

8.11 Prollenium Medical Technologies Inc.
8.11.1 Business Overview

List of Figures

Figure 1: Advantages of Derma Fillers
Figure 2: Facial Injectables Segmentation
Figure 3: Global Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global Facial Injectables Market by Type; 2023 (Percentage, %)
Figure 6: Global Facial Injectables Market by Application; 2023 (Percentage, %)
Figure 7: Global Facial Injectables Market by End User; 2023 (Percentage, %)
Figure 8: Global Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 9: Global Derma Fillers Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Derma Fillers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 11: Global Derma Fillers Facial Injectables Market by Product; 2023 (Percentage, %)
Figure 12: Global Derma Fillers Facial Injectables Market Product by Value; 2019-2023 (US$ Million)
Figure 13: Global Derma Fillers Facial Injectables Market Product by Value; 2024-2029 (US$ Million)
Figure 14: Global Neuromodulator Aesthetics Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 15: Global Neuromodulator Aesthetics Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 16: Global Facial Line Correction Treatment Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 17: Global Facial Line Correction Treatment Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 18: Global Face Lift Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 19: Global Face Lift Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 20: Global Lip Treatment Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 21: Global Lip Treatment Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 22: Global Other Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 23: Global Other Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 24: Global Hospitals and Medspa Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 25: Global Hospitals and Medspa Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 26: Global Dermatology and Cosmetic Centers Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 27: Global Dermatology and Cosmetic Centers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 28: Global Other End Users Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 29: Global Other End Users Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 30: North America Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 31: North America Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 32: North America Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 33: The US Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 34: The US Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 35: The US Facial Injectables Market by Type; 2023 (Percentage, %)
Figure 36: The US Neuromodulator Aesthetics Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 37: The US Neuromodulator Aesthetics Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 38: The US Derma Fillers Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 39: The US Derma Fillers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 40: The US Derma Fillers Facial Injectables Market Product by Value; 2019-2023 (US$ Million)
Figure 41: The US Derma Fillers Facial Injectables Market Product by Value; 2024-2029 (US$ Million)
Figure 42: Canada Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 43: Canada Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 44: Mexico Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 45: Mexico Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 46: Europe Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 47: Europe Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 48: Europe Facial Injectables Market by Type; 2023 (Percentage, %)
Figure 49: Europe Derma Fillers Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 50: Europe Derma Fillers Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 51: Europe Derma Fillers Facial Injectables Market Product by Value; 2019-2023 (US$ Million)
Figure 52: Europe Derma Fillers Facial Injectables Market Product by Value; 2024-2029 (US$ Million)
Figure 53: Europe Neuromodulator Aesthetics Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 54: Europe Neuromodulator Aesthetics Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 55: Europe Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 56: Germany Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 57: Germany Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 58: France Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 59: France Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 60: UK Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 61: UK Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 62: Italy Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 63: Italy Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 64: Spain Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 65: Spain Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 66: Rest of Europe Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 67: Rest of Europe Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 68: Asia Pacific Facial Injectables Market by Value; 2019-2023 (US$ Billion)
Figure 69: Asia Pacific Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 70: Asia Pacific Facial Injectables Market by Region; 2023 (Percentage, %)
Figure 71: China Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 72: China Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 73: Japan Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 74: Japan Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 75: India Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 76: India Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 77: South Korea Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 78: South Korea Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 79: Rest of Asia Pacific Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 80: Rest of Asia Pacific Facial Injectables Market by Value; 2024-2029 (US$ Million)
Figure 81: Rest of the World Facial Injectables Market by Value; 2019-2023 (US$ Million)
Figure 82: Rest of the World Facial Injectables Market by Value; 2024-2029 (US$ Billion)
Figure 83: Global Percentage of Population Aged 65 or Over; 2022, 2023 and 2050 (Percentage, %)
Figure 84: Global GDP per Capita; 2019-2024 (US$ Thousand)
Figure 85: Global Number of Social Media Users; 2018-2028 (Billion)
Figure 86: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2023 (Percentage, %)
Figure 87: FDA Approved Toxins
Figure 88: The US Neuromodulators Facial Injectables Players by Market Share; 2023 (Percentage, %)
Figure 89: 6+ Approved Fillers in the US
Figure 90: Six Approved Toxins in European Countries
Figure 91: 10+ Approved Fillers in European Countries
Figure 92: AbbVie Inc. Revenue by Regions; 2023 (Percentage, %)
Figure 93: Ipsen Sales by Region; 2023 (Percentage, %)
Figure 94: Revance Therapeutics, Inc. Revenue by Segment; 2023 (Percentage, %)
Figure 95: Croma-Pharma GmbH Revenue by Regions; 2023 (Percentage, %)